ESR1 and breast cancer: Reports of breast cancers in young patients show higher proportions of adverse clinic-pathologic features, Her2 neu expression, Estrogen receptors (ER)- and progesterone receptor (PR)-negative tumors, and high-grade tumors that tend to be larger and to involve regional lymph nodes [11–13].